Terms: = Leukemia AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1
3299 results:
1. A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and runx1 in myelodysplastic syndromes and acute myeloid leukemias.
Mavridou E; Lema Fernandez AG; Nardelli C; Pierini V; Quintini M; Arniani S; Di Giacomo D; Crescenzi B; Matteucci C; Sambani C; Mecucci C
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23235. PubMed ID: 38656651
[TBL] [Abstract] [Full Text] [Related]
2. Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non-high-risk acute lymphoblastic leukemia treated according to the ALL-MB 2008 protocol.
Popov A; Henze G; Tsaur G; Budanov O; Roumiantseva J; Belevtsev M; Verzhbitskaya T; Movchan L; Lagoyko S; Zharikova L; Olshanskaya Y; Riger T; Valochnik A; Miakova N; Litvinov D; Khlebnikova O; Streneva O; Stolyarova E; Ponomareva N; Novichkova G; Aleinikova O; Fechina L; Karachunskiy A
Cancer Med; 2024 Apr; 13(8):e7172. PubMed ID: 38651186
[TBL] [Abstract] [Full Text] [Related]
3. Tyrosine phosphorylation of CARM1 promotes its enzymatic activity and alters its target specificity.
Itonaga H; Mookhtiar AK; Greenblatt SM; Liu F; Martinez C; Bilbao D; Rains M; Hamard PJ; Sun J; Umeano AC; Duffort S; Chen C; Man N; Mas G; Tottone L; Totiger T; Bradley T; Taylor J; Schürer S; Nimer SD
Nat Commun; 2024 Apr; 15(1):3415. PubMed ID: 38649367
[TBL] [Abstract] [Full Text] [Related]
4. [Latest Findings on the Role of runx1 in Bone Development and Disorders].
Pan Z; Zhou X; Cao Z; Pan J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):256-262. PubMed ID: 38645858
[TBL] [Abstract] [Full Text] [Related]
5. Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia.
Yu CH; Su YH; Jou ST; Lu MY; Lin CY; Lin KH; Chang HH; Chou SW; Huang YH; Lin DT; Lin SW; Chen HY; Chang YH; Yang YL
Pathol Res Pract; 2024 Apr; 256():155287. PubMed ID: 38579576
[TBL] [Abstract] [Full Text] [Related]
6. [Veno-venous extracorporeal membrane oxygenation for capillary leak syndrome during induction chemotherapy in acute myeloid leukemia].
Okamura T; Murata S; Miyamoto K; Tane M; Okabe Y; Takeda S; Tabata S; Kosako H; Hori Y; Yamashita Y; Mushino T; Hosoi H; Sonoki T
Rinsho Ketsueki; 2024; 65(3):169-174. PubMed ID: 38569861
[TBL] [Abstract] [Full Text] [Related]
7. Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study.
Guo W; Zhao L; Huang W; Chen J; Zhong T; Yan S; Hu W; Zeng F; Peng C; Yan H
Cardiovasc Diabetol; 2024 Apr; 23(1):118. PubMed ID: 38566143
[TBL] [Abstract] [Full Text] [Related]
8. Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML.
Risueño A; See WL; Bluemmert I; de Botton S; DiNardo CD; Fathi AT; Schuh AC; Montesinos P; Vyas P; Prebet T; Gandhi A; Hasan M
Leuk Res; 2024 May; 140():107497. PubMed ID: 38564986
[TBL] [Abstract] [Full Text] [Related]
9. Dachshund Homolog 1: Unveiling Its Potential Role in Megakaryopoiesis and
Lin GL; Chang HH; Lin WT; Liou YS; Lai YL; Hsieh MH; Chen PK; Liao CY; Tsai CC; Wang TF; Chu SC; Kau JH; Huang HH; Hsu HL; Sun DS
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542074
[TBL] [Abstract] [Full Text] [Related]
10. Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial.
van der Maas NG; Versluis J; Nasserinejad K; van Rosmalen J; Pabst T; Maertens J; Breems D; Manz M; Cloos J; Ossenkoppele GJ; Floisand Y; Gradowska P; Löwenberg B; Huls G; Postmus D; Pignatti F; Cornelissen JJ
Blood Cancer J; 2024 Mar; 14(1):56. PubMed ID: 38538587
[TBL] [Abstract] [Full Text] [Related]
11. Differential prognostic values of the three AKT isoforms in acute myeloid leukemia.
Corre E; Soum C; Pfeifer R; Bessière C; Dailhau S; Marbœuf C; Meggetto F; Touriol C; Récher C; Bousquet M; Pyronnet S
Sci Rep; 2024 Mar; 14(1):7070. PubMed ID: 38528080
[TBL] [Abstract] [Full Text] [Related]
12. [Use of the ETV6/runx1 probe to verify the performance of the fluorescence in situ hybridization probe before clinical detection].
Xiao J; Zheng YC; Zhao JW; Cui CH; Wang HJ; Sun Q; Ma J; Ma YS; Song Z; Xiao ZJ; Li CW
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):48-53. PubMed ID: 38527838
[No Abstract] [Full Text] [Related]
13. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
[No Abstract] [Full Text] [Related]
14. Natural history of clonal haematopoiesis seen in real-world haematology settings.
Patel SA; Gerber WK; Zheng R; Khanna S; Hutchinson L; Abel GA; Cerny J; DaSilva BA; Zhang TY; Ramanathan M; Khedr S; Selove W; Woda B; Miron PM; Higgins AW; Gerber JM
Br J Haematol; 2024 May; 204(5):1844-1855. PubMed ID: 38522849
[TBL] [Abstract] [Full Text] [Related]
15. [Clinical analysis of allogeneic hematopoietic stem cell transplantation for seven cases of acute myeloid leukemia with BCR::ABL1 fusion].
Hao MZ; Zhao XL; Zhang XY; Shi YY; Gong M; Zhang LN; Chen SL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):995-1000. PubMed ID: 38503522
[No Abstract] [Full Text] [Related]
16. Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes.
Rodriguez-Sevilla JJ; Ganan-Gomez I; Ma F; Chien K; Del Rey M; Loghavi S; Montalban-Bravo G; Adema V; Wildeman B; Kanagal-Shamanna R; Bazinet A; Chifotides HT; Thongon N; Calvo X; Hernández-Rivas JM; Díez-Campelo M; Garcia-Manero G; Colla S
Nat Commun; 2024 Mar; 15(1):2428. PubMed ID: 38499526
[TBL] [Abstract] [Full Text] [Related]
17. Investigations of the prognostic value of runx1 mutation in acute myeloid leukemia patients: Data from a real-world study.
Wan CL; Huang YH; Huang SM; Xu YL; Tan KW; Yan-Qiu ; Shen XD; Ge SS; Cao HY; Li YY; Liu SB; Qi JJ; Dai HP; Xue SL
Leuk Res; 2024 Apr; 139():107483. PubMed ID: 38493755
[TBL] [Abstract] [Full Text] [Related]
18. AML with runx1::runx1T1 Cooperating two Mutations Relapsed Quickly after Achieving CR.
XinhongYang ; Wu Y; Yang X; Wu X; Chen Y; Zhang R; Zhang Z
Clin Lab; 2024 Mar; 70(3):. PubMed ID: 38469780
[TBL] [Abstract] [Full Text] [Related]
19. Impact of aml1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid leukemia.
Jin D; Chen H; He J; Li Y; Zheng G; Yang Y; Zhao Y; Le J; Shu W; He D; Cai Z
Target Oncol; 2024 Mar; 19(2):237-249. PubMed ID: 38466536
[TBL] [Abstract] [Full Text] [Related]
20. Usefulness of KIT mutant transcript levels for monitoring measurable residual disease in t (8;21) acute myeloid leukemia.
Sun Y; Wang X; Chen WM; Hao Y; Li LD; Li JY; Sun K; Shi ZY; Jiang H; Jiang Q; Huang XJ; Qin YZ
Hematol Oncol; 2024 Mar; 42(2):e3264. PubMed ID: 38461410
[TBL] [Abstract] [Full Text] [Related]
[Next]